In a short period of time, TransCelerate has achieved unprecedented progress, delivering tangible impact to benefit the broader biopharmaceutical industry. All this would not have been achievable without the active engagement and sponsorship from some of the most senior leaders in the industry.
In just a few years, our leaders have made significant strides toward our goal of making clinical development more efficient. TransCelerate leadership has an unwavering dedication to assessing, refining and creating processes to make the drug development environment efficient, safe and innovative.
Treasurer, TransCelerate; SVP, Head of Global Clinical Trial Operations, Merck
Corporate Secretary, TransCelerate; VP, Global Medical Affairs, Eli Lilly and Company
Pharmacovigilance Steering Committee Chair, TransCelerate; Chief Safety Officer, Janssen
Oversight Committee Chair, TransCelerate; VP, Clinical Development Quality & Risk Management, GSK
Executive Vice President, TransCelerate BioPharma Inc.
Vice President, Global Engagement & Communications, TransCelerate BioPharma Inc.
Head of Finance & Administration, TransCelerate BioPharma Inc.
Executive Director, Portfolio Management Lead, TransCelerate BioPharma Inc.
Senior Director, Portfolio Management, TransCelerate BioPharma Inc.
Board of Directors
CEO, TransCelerate BioPharma Inc.
Chair of the Board, SVP, Global Head of Pharma Regulatory and Policy, Roche
Vice Chair of the Board, EVP, Chief Development Officer, Pfizer Inc.
SVP, Global Clinical Development, Merck Research Laboratories
Chief Medical Officer, Global Head of Development, Sanofi
SVP, Head of Development, GlaxoSmith Kline
Head of Development & CMO, AbbVie
Senior Vice President, Global Development, Novo Nordisk A/S
SVP, Global Development, Amgen
Vice President, Clinical Development Organization, Eli Lilly and Company
COO of R&D and SVP, Strategic Business and Development Operations, EMD Serono
Head of Global Clinical Operations (GCO), Bristol-Myers Squibb
SVP, Head of Clinical Operations, Bayer Pharmaceutical
Head, Global Development, Janssen R&D
Director, EVP, Shionogi & Co., Ltd.
Chief Medical Officer, Boehringer Ingelheim
Head, Global Development Operations, Novartis
Chief Medical Officer, AstraZeneca
Chief Medical Officer and President, Development, Astellas Pharma